Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing capsule for acute exacerbation of chronic obstructive pulmonary disease with upper respiratory tract infection
ChiCTR2100050978Phase 4Recruiting
- Sponsor
- Shanghai Minhang District Central Hospital
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tanreqing in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Shanghai Minhang District Central Hospital. Primary endpoints: TCM clinical syndrome index and Dyspnea, cough and expectoration scale. Started Mar 2020; status: recruiting.
02
Drugs
tanreqing
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100050978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050978.